The Kitasato Institute
Minato City, Tokyo
- UEI
- TPLTEGNFTHJ4
- CAGE
- J1029
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Country - Foreign Government
- SAM.gov registration date
- Physical address
- 5 Chome Shirokane, Minato City, Tokyo 108-0072, Japan
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Trustees Of The University Of Pennsylvania | R01HD109253 | $45,441 | |
| The Trustees Of The University Of Pennsylvania | R01HD109253 | $45,441 | |
| The Trustees Of The University Of Pennsylvania | R01HD109253 | $45,900 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| The University Of Osaka | Suita, Osaka | — |
| I.r.c.m. | Montréal, QC | — |
| Centre For Cellular And Molecular Biology | Hyderabad, TG | 813920 Professional Organizations |
| National Cancer Center, National Research And Development Agency | Chuo City, Tokyo | 622310 Specialty (except Psychiatric and Substance Abuse) Hospitals |
| Stowers Institute For Medical Research | Kansas City, MO | — |
About the company
The Kitasato Institute, a foreign government research organization headquartered in Tokyo, Japan, operates as a subrecipient on federal research grants focused on developmental biology and stem-cell genetics, with all three recent awards flowing through The University of Pennsylvania as the prime recipient under National Institutes of Health funding.
The Kitasato Institute holds no federal contracts and serves exclusively as a grant subrecipient. Its federal footprint comprises three sub-awards, all under a single prime grantee and funding stream: The University of Pennsylvania has designated Kitasato as a subrecipient on three consecutive awards from the Department of Health and Human Services National Institute of Child Health and Human Development. The awards span December 2023, January 2025, and January 2026, with combined obligations of $137 thousand across the three years. The scope of work is identical across all three sub-awards — analysis of nine homeobox genes (HoxC4, 6, 8, 9, 10, 11, 12, Dlx3, and Dlx4) in spermatogonial stem cells (SSCs) by knockdown and transplantation. The institute executes siRNA knockdown in cultured mouse SSCs and conducts SSC transplantation into germ cell-depleted mouse testes to assay stem-cell activity, with planned analysis of three homeobox genes per year and subsequent assessment of functional redundancy through multi-gene knockdown. Work is performed at Kitasato's Tokyo facility with bi-monthly coordination meetings with the University of Pennsylvania and monthly invoicing to the prime recipient on an expenditure basis under NIH payment terms. The subrecipient relationship reflects Kitasato's specialized capacity in mammalian developmental biology and stem-cell research rather than federal contracting footprint or vendor positioning for competitive procurement.
Quick answers
Is The Kitasato Institute registered in SAM.gov?
Yes. The Kitasato Institute's SAM.gov registration is active through October 12, 2027.
On GovTribe
See The Kitasato Institute's full federal record
- Similar vendors